Unknown

Dataset Information

0

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors.


ABSTRACT: Cystic fibrosis (CF) is the autosomal recessive disorder most recurrent in Caucasian populations. Different mutations involving the cystic fibrosis transmembrane regulator protein (CFTR) gene, which encodes the CFTR channel, are involved in CF. A number of life-prolonging therapies have been conceived and deeply investigated to combat this disease. Among them, the administration of the so-called CFTR modulators, such as correctors and potentiators, have led to quite beneficial effects. Recently, based on QSAR (quantitative structure activity relationship) studies, we reported the rational design and synthesis of compound 2, an aminoarylthiazole-VX-809 hybrid derivative exhibiting promising F508del-CFTR corrector ability. Herein, we explored the docking mode of the prototype VX-809 as well as of the aforementioned correctors in order to derive useful guidelines for the rational design of further analogues. In addition, we refined our previous QSAR analysis taking into account our first series of in-house hybrids. This allowed us to optimize the QSAR model based on the chemical structure and the potency profile of hybrids as F508del-CFTR correctors, identifying novel molecular descriptors explaining the SAR of the dataset. This study is expected to speed up the discovery process of novel potent CFTR modulators.

SUBMITTER: Righetti G 

PROVIDER: S-EPMC7663332 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors.

Righetti Giada G   Casale Monica M   Liessi Nara N   Tasso Bruno B   Salis Annalisa A   Tonelli Michele M   Millo Enrico E   Pedemonte Nicoletta N   Fossa Paola P   Cichero Elena E  

International journal of molecular sciences 20201029 21


Cystic fibrosis (CF) is the autosomal recessive disorder most recurrent in Caucasian populations. Different mutations involving the cystic fibrosis transmembrane regulator protein (CFTR) gene, which encodes the CFTR channel, are involved in CF. A number of life-prolonging therapies have been conceived and deeply investigated to combat this disease. Among them, the administration of the so-called CFTR modulators, such as correctors and potentiators, have led to quite beneficial effects. Recently,  ...[more]

Similar Datasets

| S-EPMC7242338 | biostudies-literature
| S-EPMC8503924 | biostudies-literature
| S-EPMC4010227 | biostudies-literature
| S-EPMC3737597 | biostudies-literature
| S-EPMC7762081 | biostudies-literature
| S-EPMC5557405 | biostudies-literature
| S-EPMC6862496 | biostudies-literature
| S-EPMC3463858 | biostudies-literature
| S-EPMC8156943 | biostudies-literature
| S-EPMC5768901 | biostudies-literature